+1 915 229 3004 (U.S.) | 
+44 7452 242832 (U.K.)
+1 915 229 3004 (U.S.) | +44 7452 242832 (U.K.)
Table of Contents:
1. Executive summary
2. Market Introduction
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. Research Methodology
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Modality
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. Market Dynamics
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. Market Factor Analysis
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL Morphine MARKET, BY Dosage Form
6.1. Overview
6.2. Injection
6.3. Oral
6.4. Other Dosage Forms
7. GLOBAL Morphine MARKET, BY Application
7.1. Overview
7.2. Pain Management
7.3. Diarrhea Suppressant
7.4. Cold & Cough Suppressant
7.5. Others
8. GLOBAL Morphine MARKET, BY Distribution Channel
8.1. Overview
8.2. Hospital Pharmacies
8.3. Retail Pharmacies
8.4. Online Pharmacies
8.5. Others
9. GLOBAL Morphine MARKET, BY Distribution Channel
9.1. Overview
9.2. Hospitals & Clinics
9.3. Ambulatory Surgical Centers
9.4. Others
10. GLOBAL Morphine MARKET, by Region
10.1. Overview
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.3. Europe
10.3.1. Germany
10.3.2. France
10.3.3. U.K
10.3.4. Italy
10.3.5. Spain
10.3.6. Rest of Europe
10.4. Asia-Pacific
10.4.1. China
10.4.2. India
10.4.3. Japan
10.4.4. South Korea
10.4.5. Australia
10.4.6. Rest of Asia-Pacific
10.5. Rest of the World
10.5.1. Middle East
10.5.2. Africa
10.5.3. Latin America
11. Competitive Landscape
11.1. Overview
11.2. Competitive Analysis
11.3. Market Share Analysis
11.4. Major Growth Strategy in the Global Morphine Market,
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Global Morphine Market,
11.7. Key developments and Growth Strategies
11.7.1. New Dosage Form Launch/Application Distribution Channel
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales & Operating Income, 2022
11.8.2. Major Players R&D Expenditure. 2022
12. Company ProfileS
12.1. MALLINCKRODT PHARMACEUTICALS
12.1.1. Company Overview
12.1.2. Financial Overview
12.1.3. Dosage Forms Offered
12.1.4. Key Developments
12.1.5. SWOT Analysis
12.1.6. Key Strategies
12.2. Alcaliber
12.2.1. Company Overview
12.2.2. Financial Overview
12.2.3. Dosage Forms Offered
12.2.4. Key Developments
12.2.5. SWOT Analysis
12.2.6. Key Strategies
12.3. PURDUE PHARMA.
12.3.1. Company Overview
12.3.2. Financial Overview
12.3.3. Dosage Forms Offered
12.3.4. Key Developments
12.3.5. SWOT Analysis
12.3.6. Key Strategies
12.4. Sanofi Winthrop Industries
12.4.1. Company Overview
12.4.2. Financial Overview
12.4.3. Dosage Forms Offered
12.4.4. Key Developments
12.4.5. SWOT Analysis
12.4.6. Key Strategies
12.5. Macfarlan Smith.
12.5.1. Company Overview
12.5.2. Financial Overview
12.5.3. Dosage Forms Offered
12.5.4. Key Developments
12.5.5. SWOT Analysis
12.5.6. Key Strategies
12.6. SUN PHARMACEUTICAL INDUSTRIES.
12.6.1. Company Overview
12.6.2. Financial Overview
12.6.3. Dosage Forms Offered
12.6.4. Key Developments
12.6.5. SWOT Analysis
12.6.6. Key Strategies
12.7. Qinghai Pharmaceutical
12.7.1. Company Overview
12.7.2. Financial Overview
12.7.3. Dosage Forms Offered
12.7.4. Key Developments
12.7.5. SWOT Analysis
12.7.6. Key Strategies
12.8. Northeast Pharmaceutical Group.
12.8.1. Company Overview
12.8.2. Financial Overview
12.8.3. Dosage Forms Offered
12.8.4. Key Developments
12.8.5. SWOT Analysis
12.8.6. Key Strategies
12.9. Pfizer Inc.
12.9.1. Company Overview
12.9.2. Financial Overview
12.9.3. Dosage Forms Offered
12.9.4. Key Developments
12.9.5. SWOT Analysis
12.9.6. Key Strategies
12.10. Verve Health Care Ltd.
12.10.1. Company Overview
12.10.2. Financial Overview
12.10.3. Dosage Forms Offered
12.10.4. Key Developments
12.10.5. SWOT Analysis
12.10.6. Key Strategies
12.11. Johnson Matthey Fine Chemicals
12.11.1. Company Overview
12.11.2. Financial Overview
12.11.3. Dosage Forms Offered
12.11.4. Key Developments
12.11.5. SWOT Analysis
12.11.6. Key Strategies
12.12. Manus Aktteva Biopharma LLP
12.12.1. Company Overview
12.12.2. Financial Overview
12.12.3. Dosage Forms Offered
12.12.4. Key Developments
12.12.5. SWOT Analysis
12.12.6. Key Strategies
12.13. Mayne Pharma Group Limited
12.13.1. Company Overview
12.13.2. Financial Overview
12.13.3. Dosage Forms Offered
12.13.4. Key Developments
12.13.5. SWOT Analysis
12.13.6. Key Strategies
12.14. Daiichi Sankyo Inc.
12.14.1. Company Overview
12.14.2. Financial Overview
12.14.3. Dosage Forms Offered
12.14.4. Key Developments
12.14.5. SWOT Analysis
12.15. Taj Pharmaceuticals Limited
12.15.1. Company Overview
12.15.2. Financial Overview
12.15.3. Dosage Forms Offered
12.15.4. Key Developments
12.15.5. SWOT Analysis
12.15.6. Key Strategies
13. Appendix
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1 Global Morphine Market, Synopsis, 2018-2032
TABLE 2 Global Morphine Market, Estimates & Forecast, 2018-2032 (USD BILLION)
TABLE 3 GLOBAL Morphine MARKET, BY Dosage Form, 2018-2032 (USD BILLION)
TABLE 4 GLOBAL Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 5 GLOBAL Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 6 GLOBAL Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 7 North America Morphine MARKET, BY Dosage Form, 2018-2032 (USD BILLION)
TABLE 8 North America Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 9 North America Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 10 North America Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 11 North America Morphine MARKET, BY Country, 2018-2032 (USD BILLION)
TABLE 12 U.S. Morphine MARKET, BY Dosage Form, 2018-2032 (USD BILLION)
TABLE 13 U.S. Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 14 U.S. Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 15 U.S. Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 16 Canada Morphine MARKET, BY Dosage Form, 2018-2032 (USD BILLION)
TABLE 17 Canada Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 18 Canada Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 19 Canada Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 20 Europe Morphine MARKET, BY Dosage Form, 2018-2032 (USD BILLION)
TABLE 21 Europe Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 22 Europe Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 23 Europe Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 24 Europe Morphine MARKET, BY Country, 2018-2032 (USD BILLION)
TABLE 25 Germany Morphine MARKET, BY Dosage Form, 2018-2032 (USD BILLION)
TABLE 26 Germany Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 27 Germany Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 28 Germany Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 29 France Morphine MARKET, BY Dosage Form, 2018-2032 (USD BILLION)
TABLE 30 France Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 31 France Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 32 France Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 33 Italy Morphine MARKET, BY Dosage Form, 2018-2032 (USD BILLION)
TABLE 34 Italy Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 35 Italy Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 36 Italy Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 37 Spain Morphine MARKET, BY Dosage Form, 2018-2032 (USD BILLION)
TABLE 38 Spain Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 39 Spain Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 40 Spain Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 41 U.K Morphine MARKET, BY Dosage Form, 2018-2032 (USD BILLION)
TABLE 42 U.K Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 43 U.K Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 44 U.K Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 45 Rest of Europe Morphine MARKET, BY Dosage Form, 2018-2032 (USD BILLION)
TABLE 46 Rest of Europe Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 47 Rest of Europe Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 48 Rest of Europe Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 49 Asia Pacific Morphine MARKET, BY Dosage Form, 2018-2032 (USD BILLION)
TABLE 50 Asia Pacific Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 51 Asia Pacific Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 52 Asia Pacific Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 53 Asia Pacific Morphine MARKET, BY Country, 2018-2032 (USD BILLION)
TABLE 54 Japan Morphine MARKET, BY Dosage Form, 2018-2032 (USD BILLION)
TABLE 55 Japan Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 56 Japan Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 57 Japan Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 58 China Morphine MARKET, BY Dosage Form, 2018-2032 (USD BILLION)
TABLE 59 China Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 60 China Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 61 China Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 62 India Morphine MARKET, BY Dosage Form, 2018-2032 (USD BILLION)
TABLE 63 India Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 64 India Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 65 India Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 66 Australia Morphine MARKET, BY Dosage Form, 2018-2032 (USD BILLION)
TABLE 67 Australia Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 68 Australia Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 69 Australia Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 70 south korea Morphine MARKET, BY Dosage Form, 2018-2032 (USD BILLION)
TABLE 71 south korea Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 72 south korea Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 73 south korea Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 74 Rest of asia-pacific Morphine MARKET, BY Dosage Form, 2018-2032 (USD BILLION)
TABLE 75 Rest of asia-pacific Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 76 Rest of asia-pacific Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 77 Rest of asia-pacific Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 78 Rest of WOrld Morphine MARKET, BY Dosage Form, 2018-2032 (USD BILLION)
TABLE 79 Rest of WOrld Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 80 Rest of WOrld Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 81 Rest of WOrld Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 82 Rest of WOrld Morphine MARKET, BY Country, 2018-2032 (USD BILLION)
TABLE 83 Middle east Morphine MARKET, BY Dosage Form, 2018-2032 (USD BILLION)
TABLE 84 Middle east Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 85 Middle east Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 86 Middle east Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 87 Africa Morphine MARKET, BY Dosage Form, 2018-2032 (USD BILLION)
TABLE 88 Africa Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 89 Africa Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 90 Africa Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 91 Latin america Morphine MARKET, BY Dosage Form, 2018-2032 (USD BILLION)
TABLE 92 Latin america Morphine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 93 Latin america Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 94 Latin america Morphine MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 Research Process
FIGURE 2 Market Structure for the Global Morphine Market
FIGURE 3 Market Dynamics for the Global Morphine Market
FIGURE 4 Global Morphine Market, Share (%), BY Dosage Form, 2022
FIGURE 5 Global Morphine Market, Share (%), BY APPLICATION, 2022
FIGURE 6 Global Morphine Market, Share (%), BY DISTRIBUTION CHANNEL, 2022
FIGURE 7 Global Morphine Market, Share (%), BY DISTRIBUTION CHANNEL, 2022
FIGURE 8 Global Morphine Market, Share (%), by Region, 2022
FIGURE 9 north AMERICA: Morphine MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 Europe: Morphine MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 Asia-Pacific: Morphine MARKET, SHARE (%), BY REGION, 2022
FIGURE 12 Rest of the world: Morphine MARKET, SHARE (%), BY REGION, 2022
FIGURE 13 Global Morphine Market: Company Share Analysis, 2022 (%)
FIGURE 14 MALLINCKRODT PHARMACEUTICALS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 MALLINCKRODT PHARMACEUTICALS: SWOT ANALYSIS
FIGURE 16 Alcaliber: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 Alcaliber: SWOT ANALYSIS
FIGURE 18 PURDUE PHARMA.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 PURDUE PHARMA.: SWOT ANALYSIS
FIGURE 20 Sanofi Winthrop Industries: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 Sanofi Winthrop Industries: SWOT ANALYSIS
FIGURE 22 Macfarlan Smith..: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 Macfarlan Smith..: SWOT ANALYSIS
FIGURE 24 SUN PHARMACEUTICAL INDUSTRIES.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 SUN PHARMACEUTICAL INDUSTRIES.: SWOT ANALYSIS
FIGURE 26 Qinghai Pharmaceutical: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 Qinghai Pharmaceutical: SWOT ANALYSIS
FIGURE 28 Northeast Pharmaceutical Group.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 Northeast Pharmaceutical Group.: SWOT ANALYSIS
FIGURE 30 Pfizer Inc.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 Pfizer Inc.: SWOT ANALYSIS
FIGURE 32 Verve Health Care Ltd.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 Verve Health Care Ltd.: SWOT ANALYSIS
FIGURE 34 Johnson Matthey Fine Chemicals: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 35 Johnson Matthey Fine Chemicals: SWOT ANALYSIS
FIGURE 36 Manus Aktteva Biopharma LLP.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 37 Manus Aktteva Biopharma LLP.: SWOT ANALYSIS
FIGURE 38 Mayne Pharma Group Limited.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 39 Mayne Pharma Group Limited.: SWOT ANALYSIS
FIGURE 40 Daiichi Sankyo Inc..: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 41 Daiichi Sankyo Inc..: SWOT ANALYSIS
FIGURE 42 Taj Pharmaceuticals Limited.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 43 Taj Pharmaceuticals Limited.: SWOT ANALYSIS
Report Code :
RL6547
Published on :
Aug 2023
Request a Free Sample Report
Speak to Analyst